MAJ322Hu21 | 半胱氨酸蛋白酶抑制劑B(CSTB)單克隆抗體 | Homo sapiens (Human，人) USCN(武漢優(yōu)爾生商貿(mào)有限公司)

半胱氨酸蛋白酶抑制劑B(CSTB)單克隆抗體

該抗體是針對(duì)CSTB的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別CSTB。

免疫印跡：0.2-2μg/mL;1:500-5000
免疫組織化學(xué)：5-20μg/mL;1:50-200
免疫細(xì)胞化學(xué)：5-20μg/mL;1:50-200
最佳稀釋倍數(shù)最終由用戶決定。

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。

雜志	參考文獻(xiàn)
AIDS.	Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders [PubMed: 23291538]
International Journal of Circumpolar Health	Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer [PubMed: PMC3754495]
PLoS One.	Dysregulation of Macrophage-Secreted Cathepsin B Contributes to HIV-1-Linked Neuronal Apoptosis [PubMed: PMC3365072]
Journal of Neuroimmune Pharmacology	Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages [Pubmed:25209871]
European Journal of Cancer Supplements	A91: Endogenous inhibitors of cysteine proteases and preform of cathepsin B in cancer of reproductive system [Science: Article]
Annals of Clinical Biochemistry	Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. [pubmed:28766361]

留言咨詢

編號(hào)	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPJ322Hu01	半胱氨酸蛋白酶抑制劑B(CSTB)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
PAJ322Hu01	半胱氨酸蛋白酶抑制劑B(CSTB)多克隆抗體	WB;IHC;ICC/IF;FCM
MAJ322Hu21	半胱氨酸蛋白酶抑制劑B(CSTB)單克隆抗體	WB; IHC; ICC; IP.
SEJ322Hu	半胱氨酸蛋白酶抑制劑B(CSTB)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antigen Detection.
LMJ322Hu	半胱氨酸蛋白酶抑制劑B(CSTB)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.